These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 704768)

  • 41. An experimental model of tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of lithium on an animal model of tardive dyskinesia.
    Klawans HL; Weiner WJ; Nausieda PA
    Prog Neuropsychopharmacol; 1977; 1(1-2):53-60. PubMed ID: 569341
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical and experimental studies of phenytoin-induced hyperkinesias.
    Nausieda PA; Koller WC; Weiner WJ; Klawans HL
    J Neural Transm; 1979; 45(4):291-305. PubMed ID: 490152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia?
    Bhargava HN
    Mod Probl Pharmacopsychiatry; 1983; 21():196-205. PubMed ID: 6656783
    [No Abstract]   [Full Text] [Related]  

  • 45. Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia.
    De Keyser J
    Clin Neuropharmacol; 1991 Dec; 14(6):562-5. PubMed ID: 1837757
    [No Abstract]   [Full Text] [Related]  

  • 46. Estrogen in experimental tardive dyskinesia.
    Koller WC
    Neurology; 1981 Feb; 31(2):226-8. PubMed ID: 7193312
    [No Abstract]   [Full Text] [Related]  

  • 47. A pharmacologic model of Huntington's chorea.
    Dill RE; Dorris RL; Phillips-Thonnard I
    J Pharm Pharmacol; 1976 Aug; 28(8):646-8. PubMed ID: 11317
    [No Abstract]   [Full Text] [Related]  

  • 48. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal models for tardive dyskinesia: effects of thioridazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):291-5. PubMed ID: 616929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Striatal membrane 3H-dopamine binding in an animal model of tardive dyskinesia.
    Klawans HL; Hitri A
    Psychopharmacol Bull; 1978 Oct; 14(4):72-6. PubMed ID: 704768
    [No Abstract]   [Full Text] [Related]  

  • 53. Animal models of tardive dyskinesia: their use in the search for new treatment methods.
    Goetz CG; Klawans HL; Carvey P
    Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633
    [No Abstract]   [Full Text] [Related]  

  • 54. Mechanisms underlying tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():433-46. PubMed ID: 826999
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.